# Terazosin Hydrochloride

NDC: 71610-854
Generic name: Terazosin Hydrochloride
Labeler / Manufacturer: Aphena Pharma Solutions - Tennessee, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20200630

FDA application: ANDA074823

## Active ingredients

- TERAZOSIN HYDROCHLORIDE: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71610-854"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71610-854
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=214d9b06-8d23-3ee8-e063-6394a90a1521